Fig. 4

Overall survival depending on treatment modalities (transplantation vs no transplantation). a in the previous diagnosed 97 AEL patients (p = 0.114); b in the current 67 MDS patients (p = 0.068); c in the current AML patients (p = 0.684); d in those whose cytogenetic risk belonged to intermediate category and age were below 40 years-old (p = 0.705)